What this is
- How it works
- How it works isn't classified yet
- Tested for
- Female Infertility
- Main trialPhase 4
- “The aim of this randomized, open-label, active-controlled, parallel-group, multicenter, phase IV study is to assess the efficacy and safety of Fang Le Shu versus Guo Na Fen used for controlled ovarian stimulation in infertile women undergoing In Vitro Fertilization-Embryo Transfer.”In the company’s words, NCT06921395 on ClinicalTrials.gov
Other drugs for Female Infertility
- MibavademabRegeneron · Phase 2
- QL1012DQilu Pharmaceutical · Phase 1
- SJ04Suzhou Centergene Pharmaceuticals Co.,Ltd. · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Active, not recruiting | 26 Dec 2025 | Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET). |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026